Controlled Clinical Trial of Prophylactic Human-Leukocyte Interferon in Renal Transplantation: Effects on Cytomegalovirus and Herpes Simplex Virus Infections

New England Journal of Medicine

Volumn 300, Issue 24, 1979, Pages 1345-1349

  Cheeseman, Sarah H ^a,b,c   Rubin, Robert H ^a,b,c   Stewart, John A ^a,b,c   Tolkoff Rubin, Nina E ^a,b,c   Cosimi, A Benedict ^a,b,c   Cantell, Kari ^a,b,c   Gilbert, John ^a,b,c   Winkle, Susan ^a,b,c   Herrin, John T ^a,b,c   Black, Paul H ^a,b,c   Russell, Paul S ^a,b,c   Hirsch, Martin S ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c Central Public Health Laboratory Helsinki   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; THYMOCYTE ANTIBODY;

ADVERSE DRUG REACTION; BLOOD AND HEMOPOIETIC SYSTEM; CLINICAL STUDY; CYTOMEGALOVIRUS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG THERAPY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INJURY; INTRAMUSCULAR DRUG ADMINISTRATION; KIDNEY; KIDNEY TRANSPLANTATION; LEUKOPENIA; MAJOR CLINICAL STUDY; PREVENTION; PROPHYLAXIS; THERAPY; THROMBOCYTOPENIA; VIRUS INFECTION;

EID: 0018765996     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197906143002401     Document Type: Article

References (32)

1. Betts RF, Freeman RB, Douglas RG Jr, et al: Transmission of cytomegalovirus infection with renal allograft. Kidney Int 8: 385–392, 1975
2. Ho M, Suwansirikul S, Dowling JN, et al: The transplanted kidney as a source of cytomegalovirus infection. N Engl J Med 293: 1109–1112, 1975
3. Fiala M, Payne JE, Berne TV, et al: Epidemiology of cytomegalovirus infection after transplantation and immunosuppression. J Infect Dis 132: 421–433, 1975
4. Betts RF, Freeman RB, Douglas RG Jr, et al: Clinical manifestations of renal allograft derived primary cytomegalovirus infection. Am J Dis Child 131: 759–763, 1977
5. Suwansirikul S, Rao N, Dowling JN, et al: Primary and secondary cytomegalovirus infection: clinical manifestations after renal transplantation. Arch Intern Med 137: 1026–1029, 1977
6. Naraqi S, Jackson GG, Jonasson O, et al: Prospective study of prevalence, incidence, and source of herpesvirus infections in patients with renal allografts. J Infect Dis 136: 531–540, 1977
7. Pollard RB, Rand KH, Arvin AM, et al: Cell-mediated immunity to cytomegalovirus infection in normal subjects and cardiac transplant patients. J Infect Dis 137: 541–549, 1978
8. Pass RF, Long WK, Whitley RJ, et al: Productive infection with cytomegalovirus and herpes simplex virus in renal transplant recipients: role of source of kidney. J Infect Dis 137: 556–564, 1978
9. Rubin RH, Cosimi AB, Tolkoff-Rubin NE, et al: Infectious disease syndromes attributable to cytomegalovirus and their significance among renal transplant recipients. Transplantation 24: 458–464, 1977
10. Lopez C, Simmons RL, Mauer SM, et al: Association of renal allograft rejection with virus infections. Am J Med 56: 280–289, 1974
11. May AG, Betts RF, Freeman RB, et al: An analysis of cytomegalovirus infection and HLA antigen matching on the outcome of renal transplantation. Ann Surg 187: 110–117, 1978
12. Interferons and Interferon Inducers. Edited by NB Finter. New York, American Elsevier, 1973, pp 363–390
13. Hirsch MS, Ellis DA, Black PH, et al: Immunosuppressive effects of an interferon preparation in vivo. Transplantation 17: 234–236, 1974
14. Imanishi J, Oishi K, Kishida T, et al: Effects of interferon preparations on rabbit corneal xenograft: brief report. Arch Virol 53: 157–161, 1977
15. Merigan TC, Rand KH, Pollard RB, et al: Human leukocyte interferon for the treatment of herpes zoster in patients with cancer. N Engl J Med 298: 981–987, 1978
16. Sundmacher R, Cantell K, Neumann-Haefelin D: Combination therapy of dendritic keratitis with trifluorothymidine and interferon. Lancet 2: 687, 1978
17. Pazin GJ, Lam MT, Armstrong JA, et al: Interferon prevention of HSV reactivation. Presented at the 18th Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, October 1–4, 1978
18. Cosimi AB, Wortis HH, Delmonico FL, et al: Randomized clinical trial of antithymocyte globulin in cadaver renal allograft recipients: importance of T cell monitoring. Surgery 80: 155–161, 1976
19. Cantell K, Hirvonen S, Mogensen KE, et al: Human leukocyte interferon: production, purification, stability and animal experiments. In Vitro Monogr 3: 35–38, 1974
20. Cheeseman SH, Stewart JA, Winkle S, et al: Cytomegalovirus excretion two to fourteen years after renal transplantation. Transplant Proc 9: 71–74, 1979
21. Waner JL, Weiler TH, Stewart JA: Cytomegalovirus, Manual of Clinical Immunology. Edited by NR Rose, H Friedman. Washington, DC, American Society for Microbiology, 1976, pp 423–427
22. Pestka S, McInnes J, Havell EA, et al: Cell-free synthesis of human interferon. Proc Natl Acad Sci USA 72: 3898–3901, 1975
23. Cavalieri RL, Havell EA, Vilček J, et al: Induction and decay of human fibroblast interferon mRNA. Proc Natl Acad Sci USA 74: 4415–4419, 1977
24. Braun EW, Nankervis G: Cytomegalovirus viremia and bacteremia in renal-allograft recipients. N Engl J Med 299: 1318–1319, 1978
25. Hirsch MS, Murphy FA: Effects of anti-lymphoid sera on viral infections. Lancet 2: 37–40, 1968
26. Gardner MB, Officer JE, Parker J, et al: Induction of disseminated virulent cytomegalovirus infections by immunosuppression of naturally chronically infected wild mice. Infect Immun 10: 966–969, 1974
27. Russell PS: Antilymphocyte sera for immunosuppression: a powerful class of agents awaiting full application to patient care, Antibodies in Human Diagnosis and Therapy. Edited by E Haber, RM Krause. New York, Raven Press, 1977, pp 303–357
28. Merigan TC, Sikora K, Breeden JH, et al: Preliminary observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma. N Engl J Med 299: 1449–1453, 1978
29. Merigan TC: Pharmacokinetics and side effects of interferon in man. Tex Rep Biol Med 35: 541–547, 1977
30. Weimar W, Schellekens H, Lameijer LDF, et al: Double-blind study of interferon administration in renal transplant recipients. Eur J Clin Invest 8: 255–258, 1978
31. Dunnick JK, Galasso GJ: Clinical trials with exogenous interferon: summary of a meeting from the National Institutes of Health. J Infect Dis 139: 109–123, 1979
32. Rubin RH, Levin M, Cohen C, et al: Summary of workshop on cytomegalovirus infections during organ transplantation. J Infect Dis (in press)